Skip to main content
. 2015 Nov 4;6(3):339–346. doi: 10.1007/s13142-015-0353-9

Table 2.

Cardiovascular risk factor values, pre-treatment and post-treatment, for patients with higher-risk values at baseline

Variables N Pre-treatment (M ± SD) Post-treatment (M ± SD) p a η p 2 Correlation of Δ with percent weight loss P b
Weight (kg) 325 98.56 ± 21.40 89.16 ± 19.51 <.001 .784
BMI (kg/m2) 307 35.45 ± 7.41 32.07 ± 6.86 <.001 .764
Glucose 119 120.11 ± 30.62 106.77 ± 24.40 <.001 .191
 Women 86 119.09 ± 30.28 107.31 ± 25.18 −.031 .388
 Men 33 122.78 ± 31.75 105.36 ± 22.55 .284 .054
Triglyceridesc 85 225.36 ± 88.72 142.40 ± 66.39 <.001 .538
 Women 57 203.52 ± 55.75 150.09 ± 70.65 .242 .035
 Men 28 268.32 ± 121.57 126.75 ± 54.59 .281 .074
Total cholesterolc 150 225.85 ± 21.18 194.16 ± 25.05 <.001 .494
 Women 127 224.93 ± 19.49 196.07 ± 24.15 .339 <.001
 Men 23 230.54 ± 28.21 183.61 ± 27.82 .243 .132
LDL cholesterol 32 173.50 ± 14.88 140.50 ± 26.64 <.001 .510
 Women 25 172.50 ± 14.52 138.36 ± 28.60 .318 .061
 Men 7 177.25 ± 16.65 148.14 ± 17.51 .101 .414
HDL cholesterol 170 39.10 ± 6.48 38.84 ± 8.05 .422 .004
 Women 129 41.23 ± 5.71 41.02 ± 7.67 .066 .229
 Men 41 32.65 ± 3.88 32.00 ± 4.70 −.238 .067

Note that significant changes and correlations are indicated by italicized p values. Percent weight loss was coded as a positive value, and risk factors were coded as negative values. Effect sizes indicated by partial eta-squared (η p 2); .04, .25, and .64 indicate weak, moderate, and strong effects, respectively [20]

aPre-treatment versus post-treatment, two-way repeated measure ANOVA

bPearson’s bivariate correlations, percent weight change with change in each cardiovascular risk factor, gender-specific

cRisk factors for which there were significant time by gender interactions